Forgot your password?
New user?
Nanoparticle fear over anti-odour socks
Fragment-based Lead Discovery Conference 2008
test conference
Document Actions
Twelfth Arden House European Conference
The Development and manufacture of parenteral dosage forms: quality and regualtory issues
| Type | Conference |
|---|---|
| Language | English |
| Date |
March 12, 2007
to March 14, 2007 |
| Venue |
Royal Pharmacuetical Society of Great Britain 1 Lambeth High Street London, SE1 7JN GB |
| Chemistry Specialties |
|
| Chemistry Techniques |
|
| Contact |
Miss Susan Hughes RPSGB 1 Lambeth High Street London, SE1 7JN GB 020 7572 2640 020 7572 2506 science@rpsgb.org |
| Add event to calendar |
vCal (Windows, Linux)
iCal (Mac OS X)
|
The parenteral route remains an important route of delivery of medicines for the pharmaceutical industry for both small molecules and, increasingly, biologics. This conference will address the current best practices, challenges and trends associated with the development, manufacture and registration of parenteral products.
The Conference will provide an intensive course of study for pharmaceutical scientists working in all aspects of the research and development, production, registration and the licensing of parenteral dosage forms.
Sponsors
RPSGB, AAPS, APS
Speakers
Dr Michael Akers, Baxter, USA
Frank Guethlein, Novartis
Simon Holland, GlaxoSmithKline, UK
Paul Newby, Pfizer, UK
Christine Wurth, Roche
Steve Shire, Genentech
Dr Ralf Ostendorp, Morphosys
Karoline Bechtold-Peters, Boehringer-Ingelheim
Otto Schubert, Roche
James Drinkwater, Bioquell, UK
Dr Markus Lankers, Rap.ID Particle systems GmbH, Germany
Juergen Sigg, Novartis
Jessica Ballinger, Pfizer
Anders Lofgren, AstraZeneca
Kostas Kostarelos, University of London, UK
Emer Cooke, European Medicines Agency
Session titles
• Top issues for parenteral dosage form development
• Risk-based approach to development and manufacture
• Development and manufacture of biologicals
• Facilities, validation and plant design
• Packaging and devices
• Emerging new technologies
• Regulatory trends
Other topics
Research and Development